{"id":367146,"date":"2026-11-21T12:54:12","date_gmt":"2026-11-21T11:54:12","guid":{"rendered":"https:\/\/weedy.fr\/blog\/?p=367146"},"modified":"2026-11-21T12:54:12","modified_gmt":"2026-11-21T11:54:12","slug":"brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars","status":"publish","type":"post","link":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/","title":{"rendered":"Brains Bioceutical pr\u00e9pare une cotation au Nasdaq valoris\u00e9e 750 millions de dollars"},"content":{"rendered":"<p><strong>Brains Bioceutical Corp. pr\u00e9pare une arriv\u00e9e au Nasdaq en 2027.<\/strong> L\u2019entreprise canadienne, active dans les cannabino\u00efdes destin\u00e9s au secteur pharmaceutique, a annonc\u00e9 le 5 novembre 2026 un projet de fusion avec une soci\u00e9t\u00e9 d\u2019acquisition cot\u00e9e. L\u2019op\u00e9ration repose sur une valorisation de 750 millions de dollars et doit, si elle est men\u00e9e \u00e0 son terme, donner au groupe un acc\u00e8s renforc\u00e9 aux march\u00e9s financiers am\u00e9ricains.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_88 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Sommaire<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #43b981;color:#43b981\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #43b981;color:#43b981\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#Une_fusion_pour_acceder_a_la_Bourse_americaine\" >Une fusion pour acc\u00e9der \u00e0 la Bourse am\u00e9ricaine<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#Des_capacites_de_production_situees_au_Royaume-Uni\" >Des capacit\u00e9s de production situ\u00e9es au Royaume-Uni<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#Ce_que_le_projet_peut_changer_pour_Brains_Bioceutical\" >Ce que le projet peut changer pour Brains Bioceutical<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#Une_information_a_distinguer_de_loffre_CBD_grand_public\" >Une information \u00e0 distinguer de l\u2019offre CBD grand public<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Une_fusion_pour_acceder_a_la_Bourse_americaine\"><\/span>Une fusion pour acc\u00e9der \u00e0 la Bourse am\u00e9ricaine<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Plut\u00f4t qu\u2019une introduction en Bourse classique, Brains Bioceutical pr\u00e9voit de passer par une fusion avec une soci\u00e9t\u00e9 d\u2019acquisition cot\u00e9e, souvent appel\u00e9e SPAC. Ce type de v\u00e9hicule est d\u00e9j\u00e0 pr\u00e9sent en Bourse et a pour objet de rapprocher une entreprise non cot\u00e9e des march\u00e9s publics. Dans ce cas, la cible est Brains Bioceutical, dont la cotation au Nasdaq est envisag\u00e9e pour 2027.<\/p>\n<p>La valorisation annonc\u00e9e atteint <strong>750 millions de dollars<\/strong>. Elle traduit les ambitions de la soci\u00e9t\u00e9 sur le march\u00e9 international des cannabino\u00efdes pharmaceutiques, un segment distinct de la vente de produits de consommation \u00e0 base de chanvre ou de <a href=\"https:\/\/weedy.fr\" data-internallinksmanager029f6b8e52c=\"1\" title=\"CBD - cannabidiol\">CBD<\/a>. Une valorisation annonc\u00e9e dans le cadre d\u2019une telle op\u00e9ration ne constitue toutefois pas une garantie sur le prix futur de l\u2019action ni sur la finalisation effective du projet.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Des_capacites_de_production_situees_au_Royaume-Uni\"><\/span>Des capacit\u00e9s de production situ\u00e9es au Royaume-Uni<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Brains Bioceutical entend mettre en avant ses moyens industriels britanniques ainsi que son portefeuille de m\u00e9dicaments en d\u00e9veloppement. L\u2019entreprise se positionne sur la fabrication et le d\u00e9veloppement de cannabino\u00efdes r\u00e9pondant aux exigences du secteur pharmaceutique.<\/p>\n<p>Ce positionnement implique un cadre diff\u00e9rent de celui des produits disponibles dans les boutiques sp\u00e9cialis\u00e9es. Les m\u00e9dicaments en d\u00e9veloppement doivent suivre les \u00e9tapes et les \u00e9valuations propres au domaine pharmaceutique avant toute \u00e9ventuelle autorisation de mise sur le march\u00e9. Leur pr\u00e9sence dans un portefeuille de recherche ne signifie donc pas qu\u2019ils sont commercialis\u00e9s, ni qu\u2019ils disposent d\u00e9j\u00e0 d\u2019une indication th\u00e9rapeutique valid\u00e9e.<\/p>\n<p>Pour les lecteurs qui suivent l\u2019univers du chanvre, cette annonce illustre surtout la coexistence de plusieurs march\u00e9s autour des cannabino\u00efdes : recherche pharmaceutique, production industrielle et produits de bien-\u00eatre. Ces activit\u00e9s ne r\u00e9pondent pas aux m\u00eames r\u00e8gles, aux m\u00eames circuits de distribution ni aux m\u00eames niveaux de contr\u00f4le r\u00e9glementaire.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ce_que_le_projet_peut_changer_pour_Brains_Bioceutical\"><\/span>Ce que le projet peut changer pour Brains Bioceutical<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Une cotation au Nasdaq donnerait potentiellement \u00e0 Brains Bioceutical davantage de visibilit\u00e9 aupr\u00e8s d\u2019investisseurs internationaux. Elle pourrait aussi constituer un outil de financement pour accompagner ses activit\u00e9s industrielles et ses programmes de d\u00e9veloppement. \u00c0 ce stade, le calendrier communiqu\u00e9 vise 2027 : la r\u00e9alisation d\u00e9pendra donc des conditions habituelles li\u00e9es \u00e0 une fusion et \u00e0 une admission sur un march\u00e9 boursier.<\/p>\n<ul>\n<li><strong>Date de l\u2019annonce :<\/strong> 5 novembre 2026.<\/li>\n<li><strong>Entreprise concern\u00e9e :<\/strong> Brains Bioceutical Corp., soci\u00e9t\u00e9 canadienne.<\/li>\n<li><strong>Voie envisag\u00e9e :<\/strong> fusion avec une soci\u00e9t\u00e9 d\u2019acquisition cot\u00e9e.<\/li>\n<li><strong>March\u00e9 vis\u00e9 :<\/strong> le Nasdaq.<\/li>\n<li><strong>\u00c9ch\u00e9ance annonc\u00e9e :<\/strong> 2027.<\/li>\n<li><strong>Valorisation \u00e9voqu\u00e9e :<\/strong> 750 millions de dollars.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Une_information_a_distinguer_de_loffre_CBD_grand_public\"><\/span>Une information \u00e0 distinguer de l\u2019offre CBD grand public<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>La future op\u00e9ration concerne une entreprise orient\u00e9e vers les cannabino\u00efdes pharmaceutiques et non une \u00e9volution des r\u00e8gles de vente du <a href=\"https:\/\/weedy.fr\" data-internallinksmanager029f6b8e52c=\"1\" title=\"CBD - cannabidiol\">CBD<\/a> au grand public. Elle ne modifie pas, en elle-m\u00eame, les produits accessibles aux consommateurs ni leur statut r\u00e9glementaire. Les personnes int\u00e9ress\u00e9es par l\u2019offre de chanvre et de <a href=\"https:\/\/weedy.fr\" data-internallinksmanager029f6b8e52c=\"1\" title=\"CBD - cannabidiol\">CBD<\/a> destin\u00e9e aux adultes peuvent retrouver les r\u00e9f\u00e9rences propos\u00e9es sur <a href=\"https:\/\/weedy.fr\/\">la boutique Weedy<\/a>.<\/p>\n<p>Enfin, cette actualit\u00e9 financi\u00e8re ne doit pas \u00eatre interpr\u00e9t\u00e9e comme une promesse m\u00e9dicale. Le CBD ne soigne pas de maladie et un projet de m\u00e9dicament \u00e0 base de cannabino\u00efdes reste soumis aux \u00e9valuations scientifiques et r\u00e9glementaires applicables avant toute \u00e9ventuelle commercialisation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Brains Bioceutical Corp. pr\u00e9pare une arriv\u00e9e au Nasdaq en 2027. L\u2019entreprise canadienne, active dans les cannabino\u00efdes destin\u00e9s au secteur pharmaceutique, a annonc\u00e9 le 5 novembre 2026 un projet de fusion avec une soci\u00e9t\u00e9 d\u2019acquisition cot\u00e9e. L\u2019op\u00e9ration repose sur une valorisation de 750 millions de dollars et doit, si elle est men\u00e9e \u00e0 son terme, donner [&hellip;]<\/p>\n","protected":false},"author":95,"featured_media":367154,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"categories":[370],"tags":[],"class_list":["post-367146","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite-cbd"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.6 (Yoast SEO v28.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Brains Bioceutical Nasdaq : fusion \u00e0 750 M$ | Blog Weedy<\/title>\n<meta name=\"description\" content=\"Brains Bioceutical Nasdaq : comprendre la fusion SPAC pr\u00e9vue en 2027, sa valorisation \u00e0 750 M$ et ses enjeux pharma. D\u00e9couvrez.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ud83c\udf31Brains Bioceutical pr\u00e9pare une cotation au Nasdaq valoris\u00e9e 750 millions de dollars - Weedy.Fr\ud83c\udf31\" \/>\n<meta property=\"og:description\" content=\"Brains Bioceutical Nasdaq : comprendre la fusion SPAC pr\u00e9vue en 2027, sa valorisation \u00e0 750 M$ et ses enjeux pharma. D\u00e9couvrez.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/\" \/>\n<meta property=\"og:site_name\" content=\"Actualit\u00e9s CBD Blog - Weedy.fr\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/weedysocial\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-21T11:54:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/weedy.fr\/blog\/wp-content\/uploads\/2026\/11\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1152\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Alexandre Lacarr\u00e9\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alexandre Lacarr\u00e9\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/\"},\"author\":{\"name\":\"Alexandre Lacarr\u00e9\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#\\\/schema\\\/person\\\/54c87d7e580413b08a5b875474a54f4e\"},\"headline\":\"Brains Bioceutical pr\u00e9pare une cotation au Nasdaq valoris\u00e9e 750 millions de dollars\",\"datePublished\":\"2026-11-21T11:54:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/\"},\"wordCount\":665,\"publisher\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp\",\"articleSection\":[\"Actualit\u00e9s du CBD\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/\",\"url\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/\",\"name\":\"Brains Bioceutical Nasdaq : fusion \u00e0 750 M$ | Blog Weedy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp\",\"datePublished\":\"2026-11-21T11:54:12+00:00\",\"description\":\"Brains Bioceutical Nasdaq : comprendre la fusion SPAC pr\u00e9vue en 2027, sa valorisation \u00e0 750 M$ et ses enjeux pharma. D\u00e9couvrez.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/#primaryimage\",\"url\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp\",\"contentUrl\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp\",\"width\":2048,\"height\":1152,\"caption\":\"Une plante de chanvre d\u00e9taill\u00e9e se d\u00e9tache devant un dossier financier et une skyline new-yorkaise, \u00e9voquant un projet de cotation boursi\u00e8re.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"CBD Blog\",\"item\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Culture du CBD\",\"item\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/category\\\/culture-cbd\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s du CBD\",\"item\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/category\\\/culture-cbd\\\/actualite-cbd\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Brains Bioceutical pr\u00e9pare une cotation au Nasdaq valoris\u00e9e 750 millions de dollars\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/\",\"name\":\"Actualit\u00e9s CBD Blog - Weedy.fr\",\"description\":\"Le meilleur de l&#039;actualit\u00e9 du CBD et du chanvre en France\",\"publisher\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#organization\"},\"alternateName\":\"Weedy.fr\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#organization\",\"name\":\"Weedy.fr\",\"alternateName\":\"Weedy.fr\",\"url\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo-carre.jpg\",\"contentUrl\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo-carre.jpg\",\"width\":582,\"height\":582,\"caption\":\"Weedy.fr\"},\"image\":{\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/weedysocial\",\"https:\\\/\\\/www.instagram.com\\\/weedyfrance\\\/\"],\"description\":\"Leader en france sur la vente de produits \u00e0 base de CBD\",\"email\":\"support@weedy.fr\",\"telephone\":\"0187651030\",\"legalName\":\"Weedy.fr\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/#\\\/schema\\\/person\\\/54c87d7e580413b08a5b875474a54f4e\",\"name\":\"Alexandre Lacarr\u00e9\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e5ede08fa6bfcbfc59ce9a91c3db2da4d48324aacb4d3157006c217cb2a2b125?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e5ede08fa6bfcbfc59ce9a91c3db2da4d48324aacb4d3157006c217cb2a2b125?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e5ede08fa6bfcbfc59ce9a91c3db2da4d48324aacb4d3157006c217cb2a2b125?s=96&d=mm&r=g\",\"caption\":\"Alexandre Lacarr\u00e9\"},\"description\":\"Alexandre Lacarr\u00e9 est reconnu comme un leader innovant et influent dans l'industrie du cannabidiol (CBD). Alexandre a d\u00e9but\u00e9 sa carri\u00e8re dans le secteur des biotechnologies, o\u00f9 il a acquis une expertise pr\u00e9cieuse en recherche et d\u00e9veloppement. Passionn\u00e9 par les potentiels th\u00e9rapeutiques des compos\u00e9s naturels, il s'est rapidement orient\u00e9 vers l'industrie naissante du CBD.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/alexandre-henri-lacarr-785850186\\\/\"],\"honorificPrefix\":\"Mr\",\"gender\":\"homme\",\"knowsAbout\":[\"CBD\",\"Cannabis\",\"Copywriter\"],\"worksFor\":\"Weedy.fr\",\"url\":\"https:\\\/\\\/weedy.fr\\\/blog\\\/author\\\/fiacre\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Brains Bioceutical Nasdaq : fusion \u00e0 750 M$ | Blog Weedy","description":"Brains Bioceutical Nasdaq : comprendre la fusion SPAC pr\u00e9vue en 2027, sa valorisation \u00e0 750 M$ et ses enjeux pharma. D\u00e9couvrez.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/","og_locale":"fr_FR","og_type":"article","og_title":"\ud83c\udf31Brains Bioceutical pr\u00e9pare une cotation au Nasdaq valoris\u00e9e 750 millions de dollars - Weedy.Fr\ud83c\udf31","og_description":"Brains Bioceutical Nasdaq : comprendre la fusion SPAC pr\u00e9vue en 2027, sa valorisation \u00e0 750 M$ et ses enjeux pharma. D\u00e9couvrez.","og_url":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/","og_site_name":"Actualit\u00e9s CBD Blog - Weedy.fr","article_publisher":"https:\/\/www.facebook.com\/weedysocial","article_published_time":"2026-11-21T11:54:12+00:00","og_image":[{"width":2048,"height":1152,"url":"https:\/\/weedy.fr\/blog\/wp-content\/uploads\/2026\/11\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp","type":"image\/webp"}],"author":"Alexandre Lacarr\u00e9","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Alexandre Lacarr\u00e9","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#article","isPartOf":{"@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/"},"author":{"name":"Alexandre Lacarr\u00e9","@id":"https:\/\/weedy.fr\/blog\/#\/schema\/person\/54c87d7e580413b08a5b875474a54f4e"},"headline":"Brains Bioceutical pr\u00e9pare une cotation au Nasdaq valoris\u00e9e 750 millions de dollars","datePublished":"2026-11-21T11:54:12+00:00","mainEntityOfPage":{"@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/"},"wordCount":665,"publisher":{"@id":"https:\/\/weedy.fr\/blog\/#organization"},"image":{"@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#primaryimage"},"thumbnailUrl":"https:\/\/weedy.fr\/blog\/wp-content\/uploads\/2026\/11\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp","articleSection":["Actualit\u00e9s du CBD"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/","url":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/","name":"Brains Bioceutical Nasdaq : fusion \u00e0 750 M$ | Blog Weedy","isPartOf":{"@id":"https:\/\/weedy.fr\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#primaryimage"},"image":{"@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#primaryimage"},"thumbnailUrl":"https:\/\/weedy.fr\/blog\/wp-content\/uploads\/2026\/11\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp","datePublished":"2026-11-21T11:54:12+00:00","description":"Brains Bioceutical Nasdaq : comprendre la fusion SPAC pr\u00e9vue en 2027, sa valorisation \u00e0 750 M$ et ses enjeux pharma. D\u00e9couvrez.","breadcrumb":{"@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#primaryimage","url":"https:\/\/weedy.fr\/blog\/wp-content\/uploads\/2026\/11\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp","contentUrl":"https:\/\/weedy.fr\/blog\/wp-content\/uploads\/2026\/11\/brains-bioceutical-prepare-cotation-nasdaq-valorisee-millions-dollars.webp","width":2048,"height":1152,"caption":"Une plante de chanvre d\u00e9taill\u00e9e se d\u00e9tache devant un dossier financier et une skyline new-yorkaise, \u00e9voquant un projet de cotation boursi\u00e8re."},{"@type":"BreadcrumbList","@id":"https:\/\/weedy.fr\/blog\/brains-bioceutical-prepare-une-cotation-au-nasdaq-valorisee-750-millions-de-dollars\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"CBD Blog","item":"https:\/\/weedy.fr\/blog\/"},{"@type":"ListItem","position":2,"name":"Culture du CBD","item":"https:\/\/weedy.fr\/blog\/category\/culture-cbd\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s du CBD","item":"https:\/\/weedy.fr\/blog\/category\/culture-cbd\/actualite-cbd\/"},{"@type":"ListItem","position":4,"name":"Brains Bioceutical pr\u00e9pare une cotation au Nasdaq valoris\u00e9e 750 millions de dollars"}]},{"@type":"WebSite","@id":"https:\/\/weedy.fr\/blog\/#website","url":"https:\/\/weedy.fr\/blog\/","name":"Actualit\u00e9s CBD Blog - Weedy.fr","description":"Le meilleur de l&#039;actualit\u00e9 du CBD et du chanvre en France","publisher":{"@id":"https:\/\/weedy.fr\/blog\/#organization"},"alternateName":"Weedy.fr","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/weedy.fr\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/weedy.fr\/blog\/#organization","name":"Weedy.fr","alternateName":"Weedy.fr","url":"https:\/\/weedy.fr\/blog\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/weedy.fr\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/weedy.fr\/blog\/wp-content\/uploads\/2024\/05\/logo-carre.jpg","contentUrl":"https:\/\/weedy.fr\/blog\/wp-content\/uploads\/2024\/05\/logo-carre.jpg","width":582,"height":582,"caption":"Weedy.fr"},"image":{"@id":"https:\/\/weedy.fr\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/weedysocial","https:\/\/www.instagram.com\/weedyfrance\/"],"description":"Leader en france sur la vente de produits \u00e0 base de CBD","email":"support@weedy.fr","telephone":"0187651030","legalName":"Weedy.fr"},{"@type":"Person","@id":"https:\/\/weedy.fr\/blog\/#\/schema\/person\/54c87d7e580413b08a5b875474a54f4e","name":"Alexandre Lacarr\u00e9","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/e5ede08fa6bfcbfc59ce9a91c3db2da4d48324aacb4d3157006c217cb2a2b125?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e5ede08fa6bfcbfc59ce9a91c3db2da4d48324aacb4d3157006c217cb2a2b125?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e5ede08fa6bfcbfc59ce9a91c3db2da4d48324aacb4d3157006c217cb2a2b125?s=96&d=mm&r=g","caption":"Alexandre Lacarr\u00e9"},"description":"Alexandre Lacarr\u00e9 est reconnu comme un leader innovant et influent dans l'industrie du cannabidiol (CBD). Alexandre a d\u00e9but\u00e9 sa carri\u00e8re dans le secteur des biotechnologies, o\u00f9 il a acquis une expertise pr\u00e9cieuse en recherche et d\u00e9veloppement. Passionn\u00e9 par les potentiels th\u00e9rapeutiques des compos\u00e9s naturels, il s'est rapidement orient\u00e9 vers l'industrie naissante du CBD.","sameAs":["https:\/\/www.linkedin.com\/in\/alexandre-henri-lacarr-785850186\/"],"honorificPrefix":"Mr","gender":"homme","knowsAbout":["CBD","Cannabis","Copywriter"],"worksFor":"Weedy.fr","url":"https:\/\/weedy.fr\/blog\/author\/fiacre\/"}]}},"_links":{"self":[{"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/posts\/367146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/users\/95"}],"replies":[{"embeddable":true,"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/comments?post=367146"}],"version-history":[{"count":1,"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/posts\/367146\/revisions"}],"predecessor-version":[{"id":367152,"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/posts\/367146\/revisions\/367152"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/media\/367154"}],"wp:attachment":[{"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/media?parent=367146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/categories?post=367146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/weedy.fr\/blog\/wp-json\/wp\/v2\/tags?post=367146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}